[1]
|
Timmer, A., McDonald, J.W. and Macdonald, J.K. (2007) Aza-thioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis. Cochrane Database of Sys- tematic Reviews, 1, CD000478.
|
[2]
|
Gisbert, J.P., Linares, P.M., McNicholl, A.G., et al. (2009) Meta-analysis: The efficacy of azathioprine and mercap- topurine in ulcerative colitis. Aliment Pharmacol & The- rapeutics, 30, 126-137.
doi:10.1111/j.1365-2036.2009.04023.x
|
[3]
|
Ardizzone, S., Maconi, G., Russo, A., et al. (2006) Ran- domised controlled trial of azathioprine and 5-aminosali- cylic acid for treatment of steroid dependent ulcerative colitis. Gut, 55, 47-53. doi:10.1136/gut.2005.068809
|
[4]
|
Kirk, A.P. and Len-nard-Jones, J.E. (1982) Controlled trial of azathioprine in chronic ulcerative colitis. British Medi- cine Journal, 284, 1291-1292.
doi:10.1136/bmj.284.6325.1291
|
[5]
|
Caprilli, R., Carratù, R. and Babbini, M. (1975) Double- blind comparison of the effec-tiveness of azathioprine and sulfasalazine in idiopathic procto-colitis. Preliminary re- port. The American Journal of Digestive Diseases, 20, 115-120. doi:10.1007/BF01072336
|
[6]
|
Orth, T., Peters, M., Schlaak, J.F., et al. (2000) Myco- phenolate mofetil versus azathioprine in patients with chronic active ulcerative colitis: A 12-month pilot study. The American Journal of Gas-troenterology, 95, 1201- 1207. doi:10.1111/j.1572-0241.2000.02010.x
|
[7]
|
Adler, D.J. and Korelitz, B.I. (1990) The therapeutic ef- ficacy of 6-mercaptopurine in refractory ulcerative colitis. The American Journal of Gastroenterology, 85, 717-722.
|
[8]
|
Maté-Jiménez, J., Hermida, C., Cantero-Perona, J., et al. (2000) 6-Mercaptopurine or methotrexate added to pred- nisone induces and maintains remission in steroid-de- pendent inflammatory bowel disease. European Journal of Gastroenterology and Hepatology, 12, 1227-1233.
doi:10.1097/00042737-200012110-00010
|
[9]
|
Lichtenstein, G.R., Abreu, M.T., Cohen, R., et al. (2006) American Gastroen-terological Association Institute tech- nical review on corticos-teroids, immunomodulators, and infliximab in inflammatory bowel disease. Gastroenter- ology, 130, 940-987. doi:10.1053/j.gastro.2006.01.048
|
[10]
|
Hibi, T., Naganuma, M., Kitahora, T., et al. (2003) Low- dose azathioprine is effective and safe for maintenance of remission in patients with ulcerative colitis. Journal of Gastrotenterology, 38, 740-746.
doi:10.1007/s00535-003-1139-2
|
[11]
|
Tanaka, T., Okanobu, H., Yoshimi, S., et al. (2008) In patients with ulcerative colitis, adsorptive depletion of granulocytes and monocytes impacts mucosal level of neutrophils and clinically is most effective in steroid na- ?ve patients. Digestive and Liver Disease, 40, 731-736.
doi:10.1016/j.dld.2008.02.012
|
[12]
|
Shimoyama, T., Sawada, K., Hiwatashi, N., et al. (2001) Safety and efficacy of granulocyte and monocyte adsorp- tion apheresis in patients with active ulcerative colitis: A multicenter study. Journal of Clinical Apheresis, 16, 1-9.
doi:10.1002/jca.1000
|
[13]
|
Suzuki, Y., Yoshimura, N., Sania-badi, A.R., et al. (2004) Selective granulocyte and monocyte adsorptive apheresis as a first-line treatment for steroid na?ve patients with ac- tive ulcerative colitis: A prospective uncon-trolled study. Digestive Diseases and Science, 49, 565-571.
doi:10.1023/B:DDAS.0000026299.43792.ae
|
[14]
|
Sawada, K., Ohnishi, K., Fukui, S., et al. (1995) Leuko- cytapheresis therapy, performed with leukocyte removal filter, for inflammatory bowel disease. Journal of Gastro- enterology, 30, 322-329. doi:10.1007/BF02347507
|
[15]
|
Naganuma, M., Funakoshi, S., Sakuraba, A., et al. (2004) Granulocytapheresis is useful as an alternative therapy in patients with steroid-refractory or -dependent ulcerative colitis. Inflammmtory Bowel Diseases, 10, 251-257.
doi:10.1097/00054725-200405000-00012
|
[16]
|
Hanai, H., Wa-tanabe, F., Yamada, M., et al. (2004) Ad- sorptive granulocyte and monocyte apheresis versus pre- dnisolone in patients with corticosteroid-dependent mod- erately severe ulcerative colitis. Digestion, 70, 36-44.
doi:10.1159/000080079
|
[17]
|
Takemoto, K., Kato, J., Kuriyama, M., et al. (2007) Pre- dictive factors of efficacy of leuko-cytapheresis for ster- oid-resistant ulcerative colitis patients. Digestive and Liver Disease, 39, 422-429. doi:10.1016/j.dld.2007.01.010
|
[18]
|
Domènech, E., Hinojosa, J., Esteve-Comas, M., et al. (2004) Granulocyteaphaeresis in stero-id-dependent inflammatory bowel disease: A prospective, open, pilot study. Alimen- tary Pharmacology & Therapeutics, 20, 1347-1352.
doi:10.1111/j.1365-2036.2004.02288.x
|
[19]
|
Seo, M., Okada, M., Yao, T., et al. (1992) An index of disease activity in patients with ulcerative colitis. The American Journal of Gastro-enterology, 87, 971-976.
|
[20]
|
Sandborn, W.J. and Hanauer, S.B. (2003) Systematic re- view: The pharmacokinetic profiles of oral mesalazine formulations and mesalazine pro-drugs used in the man- agement of ulcerative colitis. Alimentary Pharma-cology & Therapeutics, 17, 29-42.
doi:10.1046/j.1365-2036.2003.01408.x
|
[21]
|
Jewell, D.P. and Truelove, S.C. (1974) Azathioprine in ulcerative colitis: Final report on controlled therapeutic trial. British Medicine Journal, 4, 627-630.
doi:10.1136/bmj.4.5945.627
|
[22]
|
Sood, A., Midha, V., Sood, N., et al. (2000) Role of aza- thioprine in severe ulcerative colitis: One-year, placebo- controlled, randomized trial. Indian Journal of Gastroen- terology, 19, 14-16.
|
[23]
|
Present, D.H., Korelitz, B.I., Wisch, N., et al. (1980) Treat- ment of Crohn’s disease with 6-mercaptopurine. A long- term, randomized, double-blind study. The New England Journal of Medicine, 302, 981-987.
doi:10.1056/NEJM198005013021801
|
[24]
|
Yamamoto, T., Umegae, S. and Matsumoto, K. (2006) Safety and clinical effi-cacy of granulocyte and monocyte adsorptive apheresis therapy for ulcerative colitis. World Journal of Gastroenterology, 12, 520-525.
|
[25]
|
Panés, J., Guilera, M., Ginard, D., et al. (2007) Treatment cost of ulcerative colitis is apheresis with Adacolumn cost-effective? Digestive and Liver Disease, 39, 617-625.
|
[26]
|
Teml, A., Schaeffeler, E., Herrlinger, K.R., et al. (2007) Thiopurine treatment in inflammatory bowel disease: Clin- ical pharmacology and implication of pharmacogeneti- cally guided dosing. Clinical Pharmacokinetics, 46, 187- 208. doi:10.2165/00003088-200746030-00001
|